Thermo Fisher Scientific might already be on your watchlist, but the real question is whether the current share price around US$474 reflects what you are actually getting for your money. Recent share ...

If you are wondering whether Boston Scientific's current share price still reflects its long term potential, the recent moves ...

Overview:  Scientific research is producing massive datasets, driving the need for advanced and scalable data storage solutions.Traditional storage systems ...

In an effort to promote crop diversification and sustainable farming practices, Agro, Rural Development & Food Processing ...

The FDA has released a draft guidance outlining how drug developers can validate new approach methodologies (NAMs) as alternatives to animal testing in preclinical drug development. The guidance, ...

A breakthrough deterministic physics kernel delivers molecular, materials, and reaction screening across three ...

Tissue Engineering (TE) strategies combining stem cells, biomaterial scaffolds, and biochemical/physical cues have emerged as promising approaches for the repair/replacement of injured tissues and ...

Indian American artificial intelligence pioneer to advise global leaders on breakthroughs in climate, health, and inclusive ...

America is going back to the moon, in the process, rejecting a decade-long policy called the "precautionary principle." ...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), a leader in innovative drug development and a vocal advocate for reducing ...

The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t mean animal testing in the US is over.

Officials with the FDA have released a draft guidance that aims to help drug developers validate new approach methodologies (NAMs) that can be used in place of animal testing. Based on human-centric ...